•4DMT advances DME gene therapy to phase 3 evaluations•VEO Ophthalmics and VitaPixel collab on 3D digital visualization system•New data supports omega-3s for glaucoma in DED patients•Aldeyra to formally appeal third reproxalap CRL•Merck releases phase 2b/3 wet AMD data for tri-specific antibody•4DMT advances DME gene therapy to phase 3 evaluations•VEO Ophthalmics and VitaPixel collab on 3D digital visualization system•New data supports omega-3s for glaucoma in DED patients•Aldeyra to formally appeal third reproxalap CRL•Merck releases phase 2b/3 wet AMD data for tri-specific antibody
HEADLINES
FEATURED
Digital health company debuts at AAO offering real-world data access, point-of-care site-finding, and a hybrid AI and human reading center for clinical trials.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
